{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003385","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.843262+00:00","generated_at":"2026-05-17T05:37:23.940320+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Silexion Therapeutics enters ATM equity facility for up to $13.17M via H.C. Wainwright","bullets":["At-the-market offering agreement with H.C. Wainwright to sell up to $13.17M of ordinary shares.","Wainwright to receive 3% commission on gross proceeds; sales may occur via Nasdaq Capital Market.","Offering terminates upon sale of all shares or earlier termination by either party.","Company not obligated to sell any shares; sales subject to effectiveness of registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003385","json":"https://secwatch.observer/filing/0001178913-25-003385.json","markdown":"https://secwatch.observer/filing/0001178913-25-003385.md","text":"https://secwatch.observer/filing/0001178913-25-003385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003385/0001178913-25-003385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003385/zk2533809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:37:23.940320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}